Literature DB >> 17280834

The insulin and EGF receptor structures: new insights into ligand-induced receptor activation.

Colin W Ward1, Michael C Lawrence, Victor A Streltsov, Timothy E Adams, Neil M McKern.   

Abstract

The insulin receptor (IR) and epidermal growth factor receptor (EGFR; also known as ErbB) families exhibit similarities in the composition of their ectodomains. The past five years have seen structures determined for all members of the EGFR family including some complexes with ligand or monoclonal antibody fragments. These structures have led to a clearer understanding of their mechanism of activation and inhibition. By contrast, obtaining equivalent understanding of the IR family has lagged behind. However, within the past year, structures of partial and complete ectodomains of the IR have been published that show that the extracellular region of the receptor adopts an unexpected 'inverted V' conformation relative to the cell membrane. This is very different from the folded-over (tethered) conformation of the unactivated EGFR and provides insight into the potential mechanism of activation of the IR.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17280834     DOI: 10.1016/j.tibs.2007.01.001

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  46 in total

1.  Structural resolution of a tandem hormone-binding element in the insulin receptor and its implications for design of peptide agonists.

Authors:  Brian J Smith; Kun Huang; Geoffrey Kong; Shu Jin Chan; Satoe Nakagawa; John G Menting; Shi-Quan Hu; Jonathan Whittaker; Donald F Steiner; Panayotis G Katsoyannis; Colin W Ward; Michael A Weiss; Michael C Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-26       Impact factor: 11.205

Review 2.  Signal transduction in podocytes--spotlight on receptor tyrosine kinases.

Authors:  Jochen Reiser; Sanja Sever; Christian Faul
Journal:  Nat Rev Nephrol       Date:  2014-01-07       Impact factor: 28.314

Review 3.  Tropomyosin-receptor-kinases signaling in the nervous system.

Authors:  Bogdan Stoleru; Alisa Madalina Popescu; Daniela Elise Tache; Oana Maria Neamtu; Ghazaleh Emami; Ligia Gabriela Tataranu; Alice Sandra Buteica; Anica Dricu; Stefana Oana Purcaru
Journal:  Maedica (Bucur)       Date:  2013-03

Review 4.  Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.

Authors:  Prasanta K Hota; Matthias Buck
Journal:  Cell Mol Life Sci       Date:  2012-06-29       Impact factor: 9.261

5.  Identification of critical residues within the conserved and specificity patches of nerve growth factor leading to survival or differentiation.

Authors:  Sidharth Mahapatra; Hrishikesh Mehta; Sang B Woo; Kenneth E Neet
Journal:  J Biol Chem       Date:  2009-09-17       Impact factor: 5.157

Review 6.  Insulin and epidermal growth factor receptor family members share parallel activation mechanisms.

Authors:  Kathryn M Ferguson; Chun Hu; Mark A Lemmon
Journal:  Protein Sci       Date:  2020-04-28       Impact factor: 6.725

Review 7.  Current views on type 2 diabetes.

Authors:  Yi Lin; Zhongjie Sun
Journal:  J Endocrinol       Date:  2009-09-21       Impact factor: 4.286

8.  Are all regions of folded proteins that undergo ligand-dependent order-disorder transitions targets for allosteric peptide mimetics?

Authors:  Aron W Fenton
Journal:  Biopolymers       Date:  2013-11       Impact factor: 2.505

9.  Lack of Cetuximab induced skin toxicity in a previously irradiated field: case report and review of the literature.

Authors:  Madhava R Kanakamedala; Satyaseelan Packianathan; Srinivasan Vijayakumar
Journal:  Radiat Oncol       Date:  2010-05-17       Impact factor: 3.481

10.  Harmonic oscillator model of the insulin and IGF1 receptors' allosteric binding and activation.

Authors:  Vladislav V Kiselyov; Soetkin Versteyhe; Lisbeth Gauguin; Pierre De Meyts
Journal:  Mol Syst Biol       Date:  2009-02-17       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.